Zivo Total Assets from 2010 to 2026

ZIVOW Stock

USD 0.05 0.00 0.00%

Zivo Bioscience Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 1.2 M in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2003-12-31

Previous Quarter

703.3 K

Current Value

559.5 K

Quarterly Volatility

2.1 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Zivo Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zivo Bioscience's main balance sheet or income statement drivers, such as Interest Expense of 25.1 K, Other Operating Expenses of 16.3 M or Total Operating Expenses of 16.2 M, as well as many indicators such as Price To Sales Ratio of 563, Dividend Yield of 0.0 or Days Sales Outstanding of 5.61. Zivo financial statements analysis is a perfect complement when working with Zivo Bioscience Valuation or Volatility modules.

Build AI portfolio with Zivo Stock

Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

The evolution of Total Assets for Zivo Bioscience Warrants provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Zivo Bioscience compares to historical norms and industry peers.

Latest Zivo Bioscience's Total Assets Growth Pattern

Below is the plot of the Total Assets of Zivo Bioscience Warrants over the last few years. Total assets refers to the total amount of Zivo Bioscience assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Zivo Bioscience Warrants books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Zivo Bioscience's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zivo Bioscience's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.64 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Zivo Total Assets Regression Statistics

	Arithmetic Mean	1,496,855
	Geometric Mean	571,010
	Coefficient Of Variation	148.44
	Mean Deviation	1,417,560
	Median	555,715
	Standard Deviation	2,221,964
	Sample Variance	4.9T
	Range	9M
	R-Value	0.28
	Mean Square Error	4.9T
	R-Squared	0.08
	Significance	0.28
	Slope	122,914
	Total Sum of Squares	79T

Zivo Total Assets History

	2026	1.2 M
	2025	1.9 M
	2024	1.6 M
	2023	555.7 K
	2022	2.1 M
	2021	9 M
	2020	220.2 K

Other Fundumenentals of Zivo Bioscience Warrants

Intangibles To Total Assets

Zivo Bioscience Total Assets component correlations

	Total Stockholder Equity	Retained Earnings	Accounts Payable	Total Liab	Common Stock	Total Assets	Net Debt	Net Receivables	Total Current Assets	Short Term Debt	Intangible Assets	Current Deferred Revenue	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Net Tangible Assets	Capital Surpluse	Capital Stock	Long Term Debt Total
Total Stockholder Equity		-0.26	-0.07	-0.95	-0.55	0.33	-0.96	0.06	0.54	-0.79	-0.21	-0.84	-0.23	0.47	-0.72	0.82	0.46	0.52	-0.57	-0.27
Retained Earnings	-0.26		-0.29	0.17	0.29	-0.31	0.27	0.48	-0.42	0.08	-0.69	0.33	0.9	0.32	0.11	-0.23	-0.85	-0.89	0.45	0.37
Accounts Payable	-0.07	-0.29		0.0	0.25	-0.25	-0.02	-0.13	-0.16	-0.01	0.31	0.34	-0.24	-0.44	-0.05	-0.09	0.41	0.32	0.41	0.03
Total Liab	-0.95	0.17	0.0		0.51	-0.02	0.92	-0.11	-0.28	0.75	0.32	0.8	0.17	-0.31	0.68	-0.69	-0.4	-0.46	0.46	0.27
Common Stock	-0.55	0.29	0.25	0.51		-0.22	0.52	0.08	-0.32	0.47	0.04	0.66	0.2	-0.19	0.44	-0.47	-0.17	-0.39	0.63	0.29
Total Assets	0.33	-0.31	-0.25	-0.02	-0.22		-0.3	-0.12	0.9	-0.25	0.26	-0.27	-0.22	0.59	-0.25	0.53	0.26	0.29	-0.4	0.01
Net Debt	-0.96	0.27	-0.02	0.92	0.52	-0.3		-0.15	-0.56	0.72	0.14	0.8	0.28	-0.39	0.66	-0.75	-0.49	-0.54	0.48	0.24
Net Receivables	0.06	0.48	-0.13	-0.11	0.08	-0.12	-0.15		-0.18	-0.21	-0.6	-0.24	0.48	0.23	-0.09	0.02	-0.42	-0.41	0.12	0.15
Total Current Assets	0.54	-0.42	-0.16	-0.28	-0.32	0.9	-0.56	-0.18		-0.23	0.24	-0.42	-0.42	0.53	-0.24	0.56	0.43	0.46	-0.48	-0.13
Short Term Debt	-0.79	0.08	-0.01	0.75	0.47	-0.25	0.72	-0.21	-0.23		0.2	0.64	-0.13	-0.51	0.94	-0.88	-0.24	-0.31	0.41	0.21
Intangible Assets	-0.21	-0.69	0.31	0.32	0.04	0.26	0.14	-0.6	0.24	0.2		0.26	-0.52	-0.24	0.05	0.03	0.45	0.47	-0.19	-0.3
Current Deferred Revenue	-0.84	0.33	0.34	0.8	0.66	-0.27	0.8	-0.24	-0.42	0.64	0.26		0.3	-0.33	0.52	-0.63	-0.35	-0.48	0.74	0.35
Long Term Debt	-0.23	0.9	-0.24	0.17	0.2	-0.22	0.28	0.48	-0.42	-0.13	-0.52	0.3		0.48	-0.17	0.02	-0.87	-0.87	0.27	0.33
Net Invested Capital	0.47	0.32	-0.44	-0.31	-0.19	0.59	-0.39	0.23	0.53	-0.51	-0.24	-0.33	0.48		-0.55	0.71	-0.32	-0.26	-0.45	0.06
Short Long Term Debt	-0.72	0.11	-0.05	0.68	0.44	-0.25	0.66	-0.09	-0.24	0.94	0.05	0.52	-0.17	-0.55		-0.93	-0.22	-0.29	0.42	0.21
Net Working Capital	0.82	-0.23	-0.09	-0.69	-0.47	0.53	-0.75	0.02	0.56	-0.88	0.03	-0.63	0.02	0.71	-0.93		0.3	0.38	-0.61	-0.23
Net Tangible Assets	0.46	-0.85	0.41	-0.4	-0.17	0.26	-0.49	-0.42	0.43	-0.24	0.45	-0.35	-0.87	-0.32	-0.22	0.3		0.94	-0.19	-0.23
Capital Surpluse	0.52	-0.89	0.32	-0.46	-0.39	0.29	-0.54	-0.41	0.46	-0.31	0.47	-0.48	-0.87	-0.26	-0.29	0.38	0.94		-0.37	-0.37
Capital Stock	-0.57	0.45	0.41	0.46	0.63	-0.4	0.48	0.12	-0.48	0.41	-0.19	0.74	0.27	-0.45	0.42	-0.61	-0.19	-0.37		0.39
Long Term Debt Total	-0.27	0.37	0.03	0.27	0.29	0.01	0.24	0.15	-0.13	0.21	-0.3	0.35	0.33	0.06	0.21	-0.23	-0.23	-0.37	0.39

Click cells to compare fundamentals

About Zivo Bioscience Financial Statements

Zivo Bioscience investors use historical fundamental indicators, such as Zivo Bioscience's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Zivo Bioscience. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	1.9 M	1.2 M
Intangibles To Total Assets	0.58	0.60

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Zivo Stock Analysis

When running Zivo Bioscience's price analysis, check to measure Zivo Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zivo Bioscience is operating at the current time. Most of Zivo Bioscience's value examination focuses on studying past and present price action to predict the probability of Zivo Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zivo Bioscience's price. Additionally, you may evaluate how the addition of Zivo Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC